ATE250664T1 - In vitro reifen von oozyten mit inhibitin/activin kombinationen - Google Patents

In vitro reifen von oozyten mit inhibitin/activin kombinationen

Info

Publication number
ATE250664T1
ATE250664T1 AT94909788T AT94909788T ATE250664T1 AT E250664 T1 ATE250664 T1 AT E250664T1 AT 94909788 T AT94909788 T AT 94909788T AT 94909788 T AT94909788 T AT 94909788T AT E250664 T1 ATE250664 T1 AT E250664T1
Authority
AT
Austria
Prior art keywords
oocytes
activin
inhibitin
combinations
vitro
Prior art date
Application number
AT94909788T
Other languages
English (en)
Inventor
Baha M Alak
Richard L Stouffer
Don P Wolf
Teresa K Woodruff
Original Assignee
Genentech Inc
Medical Res Foundation Of Oreg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Medical Res Foundation Of Oreg filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE250664T1 publication Critical patent/ATE250664T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Ink Jet (AREA)
AT94909788T 1993-02-23 1994-02-18 In vitro reifen von oozyten mit inhibitin/activin kombinationen ATE250664T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/021,404 US5563059A (en) 1993-02-23 1993-02-23 Use of human inhibin and human activin to increase the number of mature primate oocytes
PCT/US1994/002008 WO1994019455A1 (en) 1993-02-23 1994-02-18 In vitro maturation of oocytes with inhibin, activin or inhibin/activin combinations

Publications (1)

Publication Number Publication Date
ATE250664T1 true ATE250664T1 (de) 2003-10-15

Family

ID=21804022

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94909788T ATE250664T1 (de) 1993-02-23 1994-02-18 In vitro reifen von oozyten mit inhibitin/activin kombinationen

Country Status (11)

Country Link
US (2) US5563059A (de)
EP (1) EP0686192B1 (de)
JP (1) JPH08507211A (de)
AT (1) ATE250664T1 (de)
AU (1) AU672103B2 (de)
CA (1) CA2154447C (de)
DE (1) DE69433174T2 (de)
DK (1) DK0686192T3 (de)
ES (1) ES2208655T3 (de)
PT (1) PT686192E (de)
WO (1) WO1994019455A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor
DE69830598T2 (de) 1997-01-31 2006-05-18 The Horticulture And Food Research Institute Of New Zealand Limited Optische vorrichtung und methode
WO1999031977A1 (en) * 1997-12-22 1999-07-01 President And Fellows Of Harvard College Method for cryopreserving oocytes
US6071689A (en) 1997-12-31 2000-06-06 Xy, Inc. System for improving yield of sexed embryos in mammals
US6149867A (en) 1997-12-31 2000-11-21 Xy, Inc. Sheath fluids and collection systems for sex-specific cytometer sorting of sperm
US6300311B1 (en) 1998-04-14 2001-10-09 Texas Tech University Regulation of vertebrate ovarian maturation and function using growth factors
US6143564A (en) * 1998-07-07 2000-11-07 University Of Hawaii Use of the polar body chromosomes for the production of embryos and normal offspring
EP1100872A1 (de) * 1998-07-24 2001-05-23 Carnegie Institution Of Washington Verfahren zur pflege und vermehrung von keimbahn stammzellen unter verwendung von mitgliedern der familie von tgf-beta wachstumfaktoren
NZ509434A (en) 1998-07-30 2004-03-26 Univ Colorado State Res Found Equine system for non-surgical artificial insemination
US6485972B1 (en) 1998-10-15 2002-11-26 President And Fellows Of Harvard College WNT signalling in reproductive organs
US6995251B1 (en) 1999-10-28 2006-02-07 Baylor Ovary-specific genes and proteins
US20020042926A1 (en) * 1998-10-28 2002-04-11 Matzuk Martin M. Ovary-specific genes and proteins
EP1124840A4 (de) * 1998-10-28 2002-07-17 Baylor College Medicine Ovarspezifische gene und proteine
US20060079674A1 (en) * 1998-10-28 2006-04-13 Baylor College Of Medicine Wyeth Contraceptive targets
US7335737B2 (en) * 1998-10-28 2008-02-26 Baylor College Of Medicine Ovary-specific genes and proteins
AU2794100A (en) 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
EP1156821B1 (de) 1999-02-24 2007-05-02 Novo Nordisk A/S Behandlung von unfruchtbarkeit
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
DE19910394A1 (de) * 1999-03-03 2000-09-07 Schering Ag Substanzen für die Fertilitätskontrolle
CA2365449A1 (en) * 1999-04-19 2000-10-26 Kyowa Hakko Kogyo Co., Ltd. Inhibitor of the growth of androgen-independent tumor
WO2001032855A1 (en) * 1999-10-29 2001-05-10 Nexia Biotechnologies Inc. Transgenic animal production using lopu-derived oocytes
US7208265B1 (en) 1999-11-24 2007-04-24 Xy, Inc. Method of cryopreserving selected sperm cells
US20010044937A1 (en) * 1999-12-17 2001-11-22 Gerald Schatten Methods for producing transgenic animals
US7250292B2 (en) * 2000-01-26 2007-07-31 21St Century Medicine Hypertonic reduction of chilling injury
EP2258170B1 (de) 2000-05-09 2017-07-12 Xy, Llc Hochreines X-Chromosom-Lager und Y-Chromosom-Lagerpopulationen von Spermatozoiden
RU2193777C2 (ru) * 2000-06-15 2002-11-27 Ростовский НИИ акушерства и педиатрии Способ прогнозирования исходов программы эко и пэ
US7713687B2 (en) 2000-11-29 2010-05-11 Xy, Inc. System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations
AU2002237689B2 (en) * 2000-11-29 2008-01-10 Xy, Llc. System to separate frozen-thawed spermatozoa into X-chromosome bearing and Y-chromosome bearing populations
US20030135876A1 (en) * 2002-01-16 2003-07-17 Larry Mobraaten Maintenance of genetic lines using cryopreserved sperm
US6849394B2 (en) * 2002-02-21 2005-02-01 Minitube Of America Compositions comprising reproductive cell media and methods for using such compositions
WO2003076600A2 (en) * 2002-03-08 2003-09-18 Mcgill University In vitro maturation of immature human oocytes
US7763466B2 (en) * 2002-05-17 2010-07-27 Mount Sinai School Of Medicine Of New York University Mesoderm and definitive endoderm cell populations
AU2012203441B2 (en) * 2002-05-17 2015-01-29 Mount Sinai School Of Medicine Of New York University Mesoderm and definitive endoderm cell populations
US20060003446A1 (en) * 2002-05-17 2006-01-05 Gordon Keller Mesoderm and definitive endoderm cell populations
US8486618B2 (en) 2002-08-01 2013-07-16 Xy, Llc Heterogeneous inseminate system
CA2532376C (en) 2002-08-01 2015-05-12 Colorado State University Research Foundation Low pressure sperm cell separation system
BRPI0313476B1 (pt) 2002-08-15 2015-06-23 Xy Llc Citômetro de fluxo de alta resolução
US20040105858A1 (en) * 2002-08-29 2004-06-03 Kim Joanne Young Hee Kwak Diagnosis and treatment of infertility
US7169548B2 (en) 2002-09-13 2007-01-30 Xy, Inc. Sperm cell processing and preservation systems
DK2308419T3 (da) 2003-03-28 2016-06-06 Inguran Llc Fremgangsmåde til bedømmelse af farvningstilstandene for dyresperm, som skal sorteres.
NZ544103A (en) 2003-05-15 2010-10-29 Xy Llc Efficient haploid cell sorting for flow cytometer systems
JP5144073B2 (ja) * 2003-11-26 2013-02-13 メルク セローノ ソシエテ アノニム 卵母細胞の成熟のためのil−6−型サイトカインの使用
US20090155218A1 (en) * 2004-03-10 2009-06-18 Alberto Hayek Compositions and methods for growth of embryonic stem cells
JP2007531523A (ja) 2004-03-29 2007-11-08 モンサント テクノロジー エルエルシー Xまたはy染色体担持豊富化集団に仕分けるための精子懸濁液
WO2005113752A2 (en) 2004-05-17 2005-12-01 The General Hospital Corporation Methods and compositions for producing germ cells from peripheral blood derived germline stem cells
CA2574499C (en) 2004-07-22 2016-11-29 Monsanto Technology Llc Process for enriching a population of sperm cells
RU2281778C1 (ru) * 2005-04-21 2006-08-20 Мария Львовна Семенова Способ культивирования зиготы и/или эмбриона и композиция для добавления в среду культивирования зигот и/или эмбрионов
RU2281777C1 (ru) * 2005-04-21 2006-08-20 Мария Львовна Семенова Способ управления качеством ооцитов и композиция для добавления в среду культивирования ооцитов
US7618770B2 (en) 2005-07-29 2009-11-17 Xy, Inc. Methods and apparatus for reducing protein content in sperm cell extenders
US8874380B2 (en) 2010-12-09 2014-10-28 Rutgers, The State University Of New Jersey Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
US20080113431A1 (en) * 2006-11-15 2008-05-15 Mariposa Biotechnology, Inc. Methods and compositions for cryopreserving oocytes
US20080113432A1 (en) * 2006-11-15 2008-05-15 Mariposa Biotechnology, Inc. Methods and compositions for reanimating cryopreserved oocytes
US8903660B2 (en) 2010-06-24 2014-12-02 The Invention Science Fund I, Llc Rejuvenation or preservation of germ cells
NZ706806A (en) 2011-04-14 2016-12-23 Gen Hospital Corp Compositions and methods for autologous germline mitochondrial energy transfer
EP2726601B1 (de) 2011-06-29 2018-12-26 The General Hospital Corporation Zusammensetzungen und verfahren zur verbesserung des bioenergetischen status bei weiblichen keimzellen
EP3713552A1 (de) 2017-11-23 2020-09-30 Biosearch S.A. Verfahren zur erhöhung der embryonenimplantationsrate bei einer patientin, die unter polyzystischem ovarialsyndrom leidet
WO2022094628A2 (en) * 2020-11-02 2022-05-05 Conception Biosciences, Inc. In vitro derivation of gonadal somatic cells
CN114913972B (zh) * 2021-12-10 2023-12-01 北京大学第三医院(北京大学第三临床医学院) 预测受试者卵巢刺激过程中获得的卵母细胞数量的系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
IE881133L (en) * 1988-04-14 1989-10-14 Univ Dublin In-vitro culture of bovine embryos
IL94184A0 (en) * 1989-05-01 1991-01-31 Granada Biosciences Inc In vitro maturation of bovine oocytes
JPH03173805A (ja) * 1989-09-11 1991-07-29 Ajinomoto Co Inc 卵分割促進剤
WO1991010445A1 (en) * 1990-01-08 1991-07-25 Genentech, Inc. Method for increasing fertility in females
US5102868A (en) * 1990-01-08 1992-04-07 Genentech, Inc. Method for inhibiting follicular maturation
US5166190A (en) * 1990-01-08 1992-11-24 Genentech, Inc. Method for increasing fertility in males
CA2072475A1 (en) * 1991-07-01 1993-01-02 Tanja Dominko In vitro maturation of denuded bovine oocytes

Also Published As

Publication number Publication date
PT686192E (pt) 2004-02-27
EP0686192B1 (de) 2003-09-24
JPH08507211A (ja) 1996-08-06
US5563059A (en) 1996-10-08
AU672103B2 (en) 1996-09-19
ES2208655T3 (es) 2004-06-16
AU6249794A (en) 1994-09-14
CA2154447A1 (en) 1994-09-01
DE69433174T2 (de) 2004-07-01
DK0686192T3 (da) 2004-02-02
US5693534A (en) 1997-12-02
CA2154447C (en) 2005-04-19
WO1994019455A1 (en) 1994-09-01
EP0686192A1 (de) 1995-12-13
DE69433174D1 (de) 2003-10-30

Similar Documents

Publication Publication Date Title
DE69433174D1 (de) In vitro reifen von oozyten mit inhibitin/activin kombinationen
NO303261B1 (no) Apparat for plantekultivering
ATE193550T1 (de) Rekonstruiertes knorpelgewebe
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
DE3874019D1 (de) Verfahren zur konservierung von transplantierbaren, in vitro kultivierten epithelgeweben.
BG35465A3 (en) Method for preparing derivatives of 1-(cyclohexyl)-4-aryl-4- piperidine carbonic acid
AU656493B2 (en) Regulation of immunoglobin production by interleukin-4 and interleukin-9
ATA101979A (de) Verfahren zur aktivierung von wasser, insbesondere der wachstumsfoerderung sowie desintegrator und vorrichtung zur durchfuehrung des verfahrens
DE69324901D1 (de) Tcmtb auf einem festen träger in pulverform
AU566174B2 (en) Process to preserve acid-producing bacteria
DE69624937D1 (de) Verfahren zur verminderung der strahlentherapie oder der radiomimetischen chemotherapie bei der transplantation von hematopoietischen, pluripotenten zellen
FI851619A7 (fi) Menetelmä epifyyttikasviasetelmien kasvatusta ja kuljetusta varten.
CA2177043A1 (en) Hepatoblasts and method of isolating same
DE69535263D1 (de) Angiotensin ii zur verbesserung der befruchtung
TW349124B (en) Osmotically controlled fermentation process for the preparation of acarbose
NO20006545L (no) Fremgangsmåte for in vitro modning av humane kjönnsceller
DK4586D0 (da) Fremgangsmaade til formering af begoniearter
AU4075093A (en) Cellular aggregate stabilized culture and process for the development of embryos from a proembryogenic strain for use in vine regeneration techniques
DE60040793D1 (de) Verfahren zur vermehrung von stammzellen
UA18979A (uk) Спосіб коhсервування сперми риб
AU1402495A (en) Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
UA16856A1 (uk) Спосіб коhсервуваhhя ембріоhів ссавців
UA8596A1 (uk) Субстракт для вирощуваhhя істівhого гриба гливи звичайhої
MD638G2 (ro) Mediu pentru decongelarea spermei de taur
UA9924A (uk) Спосіб вирощування крупномірної деревини сосни

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0686192

Country of ref document: EP